Ildoo Chung | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Ildoo Chung | Pharmacology | Best Researcher Award

 Professor, Pusan National University South Korea

Ildoo Chung is a distinguished professor in the Department of Polymer Science and Engineering at Pusan National University, Korea. With a career spanning over two decades, he specializes in polymer chemistry, functional materials, and advanced biomedical engineering applications. Dr. Chung has held prominent academic and administrative positions, including department head and associate dean. He actively contributes to global research through editorial roles, conference leadership, and professional society memberships. Renowned for his dedication to education and innovation, Dr. Chung’s work bridges academia and industry, advancing polymer science worldwide.

Publication Profile

Scopus

Orcid

google scholar

🎓 Education

Ph.D. in Polymer Science & Engineering, Pusan National University, Korea (2000.08). M.S. in Polymer Science & Engineering, Pusan National University, Korea (1997.02). B.S. in Polymer Science & Engineering, Pusan National University, Korea (1995.02)

💼 Experience

Professor, Pusan National University, Korea (2014–present). Associate Dean, College of Engineering, Pusan National University (2018–2020). Department Head, Polymer Science & Engineering, Pusan National University (2013–2017). Visiting Associate Professor, University of Tennessee, USA (2012–2013). Assistant/Associate Professor, Pusan National University (2005–2014). Postdoctoral Fellow, University of Alabama at Birmingham, USA (2000–2002)

🏆 Awards & Honors

Member, Board of Directors, The Polymer Society of Korea. Editorial roles in Journal of Adhesion and Interface, IJMSE, and others. Numerous conference chair and committee memberships globally. Reviewer for high-impact journals like Macromolecular Research and Dental Materials. Recipient of national and international recognition for polymer research

🔬 Research Focus

Development of functional polymers for drug delivery and biomedical applications. Advanced polymer composites and their industrial applications. Interface engineering in polymer systems for sustainability. Nanostructured materials and their multifunctional properties. Polymer chemistry for healthcare innovations

Conclusion

Professor Ildoo Chung’s academic and professional journey reflects a commitment to advancing knowledge in polymer science and materials engineering. His leadership, research, and editorial work have significantly impacted the field, making him a deserving candidate for the Best Researcher Award. With continued efforts in interdisciplinary collaboration and practical applications, he has the potential to further elevate his influence and contributions to global scientific advancements.

Publication Top Notes

  • Title: L-Threonine-Derived Biodegradable Polyurethane Nanoparticles for Sustained Carboplatin Release
    Year: 2024
    Authors: Seoeun Oh, Soo-Yong Park, Hyung Il Seo, Ildoo Chung
    Citation: DOI: 10.3390/pharmaceutics17010028

 

  • Title: Derivatization of Hyaluronan to Target Neuroblastoma and Neuroglioma Expressing CD44
    Year: 2024
    Authors: Vo Van Giau, Giau Van Vo, Van-Giau Vo, Ildoo Chung, Chang-Sik Ha, Seong An, Yang H. Yun
    Citation: DOI: 10.3390/pharmaceutics16060836

 

  • Title: Depolymerized Chitosan-g-[Poly(MMA-co-HEMA-cl-EGDMA)] Based Nanogels for Controlled Local Release of Bupivacaine
    Year: 2023
    Authors: Sivagangi Reddy Nagella, Soojeong Choi, Soo-Yong Park, Chang-Sik Ha, Youngmi Jung, Ramesh Kumar Chitumalla, Joonkyung, Ji-Young Yoon, Ildoo Chung
    Citation: DOI: 10.3390/ijms242216470

 

  • Title: Effects of Recycled Polymer on Melt Viscosity and Crystallization Temperature of Polyester Elastomer Blends
    Year: 2023
    Authors: Ji-Eun Lee, Jin-Woo Lee, Jae-Wang Ko, Kyung-Il Jo, Hyun-Ju Park, Ildoo Chung
    Citation: DOI: 10.3390/ma16176067

 

  • Title: Carboxymethyl cellulose/montmorillonite bionanocomposite films incorporated with polyhedral oligomeric silsesquioxane
    Year: 2022
    Authors: Jin H., Yan Y.-Z., Lee C.S., Lee J.-H., Chung I., Ha C.-S.
    Citation: DOI: 10.1080/09276440.2022.2151262

 

  • Title: Effect of the Surface Modification of Silica Nanoparticles on the Viscosity and Mechanical Properties of Silica/Epoxy Nanocomposites
    Year: 2022
    Authors: Kim T., Kwon S.-H., Kim H.J., Lim C.-S., Chung I., Lee W.-K., Seo B.
    Citation: DOI: 10.1080/09276440.2022.2094572

 

  • Title: Polydopamine/Polypyrrole Modified Graphite Felt Enhances Biocompatibility for Electroactive Bacteria and Power Density of Microbial Fuel Cell
    Year: 2022
    Authors: Kim M., Li S., Kong D.S., Song Y.E., Park S.-Y., Kim H.-I., Jae J., Chung I., Kim J.R.
    Citation: EID: 2-s2.0-85133636105

 

  • Title: Polyol and Polyurethane Containing Bisphenol-Z: Synthesis and Application for Toughening Epoxy
    Year: 2022
    Authors: Lee D.Y., Kim H.J., Kim H.-G., Lim C.-S., Chung I., Seo B.
    Citation: DOI: 10.1002/app.53013

 

  • Title: ROS- and pH-Responsive Polydopamine Functionalized Ti₃C₂Tₓ MXene-Based Nanoparticles as Drug Delivery Nanocarriers with High Antibacterial Activity
    Year: 2022
    Authors: Wei-Jin Zhang, Shuwei Li, Veena Vijayan, Lee Jun Seok, Sung Soo Park, Xiuguo Cui, Ildoo Chung, Jaejun Lee, Suk-kyun Ahn, Jung Rae Kim, et al.
    Citation: DOI: 10.3390/nano12244392

 

  • Title: Dual (pH- and ROS-) Responsive Antibacterial MXene-Based Nanocarrier for Drug Delivery
    Year: 2022
    Authors: Wei-Jin Zhang, Shuwei Li, Yong-Zhu Yan, Sung Soo Park, Anandhu Mohan, Ildoo Chung, Suk-kyun Ahn, Jung Rae Kim, Chang-Sik Ha
    Citation: DOI: 10.3390/ijms232314925

 

 

Srijan Acharya | Molecular Pharmacology | Excellence in Research

Posted on by ScienceFather

Dr. Srijan Acharya | Molecular Pharmacology | Excellence in Research

Dr at St. Jude Children’s Research Hospital, United States

Srijan Acharya is a dedicated scientist with expertise in molecular pharmacology and cancer genomics. He is currently a Post-Doctoral Research Fellow at St. Jude Children’s Research Hospital, focusing on childhood cancer research. With 32 published scientific articles and a total citation count of over 385, his work has contributed significantly to biomarker discovery, receptor pharmacology, and immuno-oncology. His research aims to address therapeutic resistance in pediatric malignancies through small molecule screening. Srijan is fluent in English, Bangla, and Hindi, with basic knowledge of Korean.

Profile

Scholar

🎓 Education

PhD in Molecular Pharmacology from Chonnam National University, South Korea (2020). M.Sc. in Biotechnology from North South University, Bangladesh (2015). BPHRM in Pharmacy from East West University, Bangladesh (2012). His academic journey has provided a strong foundation in receptor pharmacology and molecular biology, guiding his transition into cancer research.

💼 Experience

Post-Doctoral Research Fellow, Pharmacy Department, St. Jude Children’s Research Hospital, USA (2023-Present). Post-Doctoral Research Fellow, Pathology Department, Mitchell Cancer Institute, USA (2020-2023). Executive Officer, Research and Development, Square Pharmaceutical PLC, Bangladesh (2012-2013). His experience spans academia and industry, with a focus on cancer research, receptor signaling, and small molecule screening.

🏆 Awards and Honors

Inducted into Sigma Xi, The Scientific Research Honor Society (2023). Recognized in Who’s Who in America by Marquis (2023). Young Investigator Award at AACR conference by AAISCR (2022). Best Presenter Award from China Pharmaceutical University (2021). Global Scholarship from Chonnam National University, Korea (2015). These accolades reflect his significant contributions to molecular pharmacology and cancer research.

🔬 Research Focus

Srijan’s research primarily investigates the role of molecular signaling in cancer, focusing on the interaction of nicotine receptors with GPCRs and their impact on cancer progression. At St. Jude, his work focuses on childhood cancers, particularly Ewing sarcoma and rhabdomyosarcoma. He uses small molecule screening to discover potential therapeutic agents and aims to overcome therapeutic resistance in pediatric cancers.

Conclusion

Srijan Acharya is a highly accomplished and promising researcher whose contributions to cancer pharmacology and molecular biology are noteworthy. His interdisciplinary research approach, combined with his dedication to advancing pediatric oncology, positions him as a leader in the field. With continued mentorship and broader collaborative efforts, Acharya is well poised for even greater achievements, further solidifying his place as an influential scientist in the biomedical community.

📚Publications 

  • Title: Unveiling the intracellular dynamics of α4β2 nAChR-mediated ERK activation through the interplay of arrestin, Gβγ, and PKCβII
    Year: 2024
    Authors: Dooti K, Acharya S, Wang S, Kim K.M.

 

  • Title: Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer
    Year: 2023
    Authors: Acharya S, Anand S, Khan MA, Zubair H, Srivastava SK, Singh S, Singh AP

 

  • Title: MYB exhibits racially disparate expression, clinicopathologic association, and predictive potential for biochemical recurrence in prostate cancer
    Year: 2023
    Authors: Md Khan, S Acharya, S Anand, F Sameeta, P Pramanik, C Keel, S Singh, James E Carter, S Dasgupta, A Singh

 

  • Title: Comparative study of the molecular mechanisms underlying the G protein and β-arrestin-dependent pathways that lead to ERKs activation upon stimulation by dopamine D2 receptor
    Year: 2023
    Authors: Liu H, Acharya S, Sudan SK, Hu L, Wu C, Cao Y, Li H, Zhang X

 

  • Title: Frequent loss of cacna1c, a calcium voltage-gated channel subunit is associated with lung adenocarcinoma progression and poor prognosis
    Year: 2023
    Authors: Dasgupta, S., Acharya, S., Khan, M. A., Pramanik, P., Marbut, S. M., Yunus, F., Galeas, J. N., Singh, S., Singh, A. P., and Dasgupta, S.

 

  • Title: Nicotine causes alternative polarization of macrophages via Src-mediated STAT3 activation: Potential pathobiological implications
    Year: 2022
    Authors: Acharya S, Saranyutanon S, Deshmukh SK, Khan MA, Singh S, Singh AP

 

  • Title: β-Arrestin1 and GRK2 play permissive roles in Src-mediated endocytosis of α4β2 nicotinic acetylcholine receptor
    Year: 2021
    Authors: Acharya S, Kundu D, Kim KM

 

  • Title: Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson’s Disease
    Year: 2021
    Authors: Acharya S, Kim KM

 

  • Title: Clinicopathologic significance and race-specific prognostic association of MYB overexpression in ovarian cancer
    Year: 2021
    Authors: Miree, O., Srivastava, …Acharya S.et al.

 

  • Title: Metabotropic signaling cascade involved in α4β2 nicotinic acetylcholine receptor-mediated PKCβII activation
    Year: 2020
    Authors: Acharya S, D. Kundu, H.J. Choi, and K.M. Kim

 

  • Title: Catalpol and Mannitol, Two Components of Rehmannia glutinosa, Exhibit Anticonvulsant Effects Probably via GABAA Receptor Regulation
    Year: 2019
    Authors: Acharya S, Kim M., Botanas C. J., Custodio R. J., Lee H. J., Sayson L. V., Kim H. J.

 

  • Title: Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors
    Year: 2017
    Authors: Paudel S, Acharya S, Yoon G, Kim K.M., & Cheon S.H.